Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers
According to the state government, it will also provide support to special projects such as preclinical testing, genome sequencing in the private sector, private sector BSL-3 lab-vaccine development and manufacturing and testing and certification laboratories
Subscribe To Our Newsletter & Stay Updated